Diabetic macular oedema ( DME ) is severe form of Diabetic Retinopathy affecting vision.
DME can occur in any stage of diabetes.
Thus, the importance of regular eye check-up for diabetic patients is must. At least once in a year get your eyes fully tested.
Most of the people are unaware of this complication. And many times when I ask my patient about eye test I get answers like , "I got my eye glasses power checked and changed or I don't have cataract. "
Eye check-up for diabetic person is checking the back part of the eye which is called as Retina.
Once DME is diagnosed, immediate treatment is necessary to ensure better outcomes and prevent vision loss.
Diabetic macular oedema (DME) can be treated using laser therapy and/or intravitreal injections with vascular endothelial growth factor (VEGF) inhibitor injections.
Anti-VEGFs are able to reduce oedema, macula thickening and vascular permeability
They are the treatment of choice for DME because they can improve the patient’s vision ,produce good results and have a low risk of complications.
3 anti-VEGFs are available in market. bevacizumab and ranibizumab, aflibercept .
In some patients, there may be a need for a combination therapy of both laser treatment and intravitreal anti-VEGF injections. DME treatment needs to be personalised to cater to each patient’s conditions. This applies to the frequency of intravitreal anti-VEGF injections, with the injections given as per the patient’s condition instead of following a strict routine frequency protocol.
DME can occur in any stage of diabetes.
Thus, the importance of regular eye check-up for diabetic patients is must. At least once in a year get your eyes fully tested.
Most of the people are unaware of this complication. And many times when I ask my patient about eye test I get answers like , "I got my eye glasses power checked and changed or I don't have cataract. "
Eye check-up for diabetic person is checking the back part of the eye which is called as Retina.
Once DME is diagnosed, immediate treatment is necessary to ensure better outcomes and prevent vision loss.
Diabetic macular oedema (DME) can be treated using laser therapy and/or intravitreal injections with vascular endothelial growth factor (VEGF) inhibitor injections.
Anti-VEGFs are able to reduce oedema, macula thickening and vascular permeability
They are the treatment of choice for DME because they can improve the patient’s vision ,produce good results and have a low risk of complications.
3 anti-VEGFs are available in market. bevacizumab and ranibizumab, aflibercept .
In some patients, there may be a need for a combination therapy of both laser treatment and intravitreal anti-VEGF injections. DME treatment needs to be personalised to cater to each patient’s conditions. This applies to the frequency of intravitreal anti-VEGF injections, with the injections given as per the patient’s condition instead of following a strict routine frequency protocol.
No comments:
Post a Comment